AbbVie Says FDA Lifts Partial Hold on Phase 3 Trial

Date : 06/24/2019 @ 1:38PM
Source : Dow Jones News
Stock : Roche Holding (QX) (RHHBY)
Quote : 38.23  0.06 (0.16%) @ 8:59PM

AbbVie Says FDA Lifts Partial Hold on Phase 3 Trial

Historical Stock Chart

6 Months : From May 2019 to Nov 2019

Click Here for more AbbVie Charts.

By Michael Dabaie


AbbVie (ABBV) said the U.S. Food and Drug Administration lifted the partial clinical hold placed on Canova, a Phase 3 trial evaluating venetoclax for the investigational treatment of relapsed/refractory multiple myeloma.

The trial evaluates venetoclax in combination with dexamethasone versus pomalidomide in combination with dexamethasone in patients with relapsed/refractory multiple myeloma positive for the translocation (11;14) abnormality.

The FDA removed the partial clinical hold based upon agreement on revisions to the study protocol, including new risk mitigation measures, protocol-specified guidelines and updated futility criteria, AbbVie said.

All other clinical trials evaluating venetoclax in multiple myeloma remain on partial clinical hold, the company said. In March, AbbVie said the FDA placed a partial clinical hold on all trials evaluating venetoclax for multiple myeloma, following a review of data from the Phase 3 Bellini trial. Venetoclax is being developed by AbbVie and Roche (RHHBY).


Write to Michael Dabaie at


(END) Dow Jones Newswires

June 24, 2019 09:23 ET (13:23 GMT)

Copyright (c) 2019 Dow Jones & Company, Inc.

Latest RHHBY Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Your Recent History
Gulf Keyst..
FTSE 100
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.